Tag Archives: GenVec

Low floats have been the name of the game for a number of biotech companies this week, with some seemingly inexplicable runs only explained by low float, high-volume spikes. Here is another one. The company is GenVec Inc (NASDAQ:GNVC), and...

GenVec, Inc. (NASDAQ:GNVC) announced that it has achieved a milestone in its collaboration with Novartis (NVS) for the development of treatments for hearing and balance disorders. Novartis has dosed the first patient in a clinical study to assess the safety, tolerability, and efficacy of intra-labyrinthine CGF166 in patients with severe hearing loss....

Sign Up Now For Our FREE Small Cap Newsletter